MedPath

Dietary Sodium, Oxidative Stress, and Pulsatile Hemodynamics

Not Applicable
Recruiting
Conditions
Sodium Excess
Interventions
Dietary Supplement: High Sodium
Other: Placebo
Registration Number
NCT04233957
Lead Sponsor
University of Delaware
Brief Summary

High sodium diets impair vascular function, which may influence the work of the heart. This investigation is designed to determine if this change in vascular function results in a greater workload in the heart and if people who regularly exercise are protected from these effects.

Detailed Description

Excess dietary sodium is associated with cardiac hypertrophy independent of changes in blood pressure. Importantly, increased arterial pulsatile load predicts left ventricular hypertrophy, and thus presents a potential mechanism through which high dietary sodium augments cardiovascular disease risk.

While high sodium diets impair vascular function via an increase in oxidative stress, how high sodium influences central pulsatile hemodynamics is not known. This project aims to a) determine how impaired vascular function affects pulsatile hemodynamics and thus influences the work of the heart during periods of high sodium consumption and b) examine whether regular aerobic exercise and/or fitness protects against the deleterious effects of excess sodium.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Healthy individuals (age 21-45) who are either sedentary (1 or less days of exercise per week during past year) or habitually active (4 or more days of aerobic exercise per week for a minimum of 1 year)
Exclusion Criteria
  • Body mass index <18 or >35
  • Systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90
  • Blood donation within past 8 weeks,
  • Glucose 6 phosphate dehydrogenase (G6PD) deficiency
  • A history of cancer, diabetes, or any other chronic disease
  • A history of any heart disease
  • A history of hormone therapy
  • Use of nicotine products
  • Pregnancy
  • Nursing mothers
  • Participation in regular physical activity greater than 1 day/week- but less than 4 days/week

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
High SodiumHigh SodiumConsumption of an extra 3900 mg of dietary sodium per day.
PlaceboPlaceboControl Condition
Primary Outcome Measures
NameTimeMethod
Conduit artery endothelium-dependent dilationOn the 10th day of each arm.

Brachial artery flow mediated dilation (FMD) will be assessed by duplex ultrasound as an index of conduit artery endothelial function.

Reflected Pulse Wave AmplitudeOn the 10th day of each arm.

Aortic pressure-flow relations will be assessed non-invasively using echocardiography and peripheral artery applanation tonometry. Wave separation analysis will be used to calculate reflected pulse wave amplitude.

Arterial StiffnessOn the 10th day of each arm.

Carotid-femoral pulse wave velocity (cf-PWV) will be assessed via applanation tonometry as an index of aortic stiffness. cf-PWV will be calculated as the difference in timing of of pulse waves at the carotid and femoral arteries divided by the distance between measurements.

Secondary Outcome Measures
NameTimeMethod
Wave reflection timingOn the 10th day of each arm.

Aortic pressure-flow relations will be assessed non-invasively using echocardiography and peripheral artery applanation tonometry. Wave separation analysis will be used to calculate reflected wave transit time.

Forward Pulse Wave AmplitudeOn the 10th day of each arm.

Aortic pressure-flow relations will be assessed non-invasively using echocardiography and peripheral artery applanation tonometry. Wave separation analysis will be used to the amplitude of the forward traveling pulse wave.

24 Hour Blood PressureThe morning of day 9 through the morning of day 10 for each arm.

24 hour blood pressure monitoring will be performed using an ambulatory blood pressure monitor device. Average day and nighttime systolic, diastolic, and mean blood pressures will be determined.

Trial Locations

Locations (1)

Department of Kinesiology and Applied Physiology, University of Delaware

🇺🇸

Newark, Delaware, United States

© Copyright 2025. All Rights Reserved by MedPath